eGFR and microalbuminuria: a powerful duo

Estimates of glomerular filtration rate (GFR) have been the mainstay of kidney functional assessment for some time and have been the most widely relied upon test to predict progression to end-stage renal disease (ESRD). Urinary microalbuminuria (MAU) has more recently been added to the assessment of chronic kidney disease. In this month's issue of the Journal of the American Society of Nephrology, researches confirm that the use of these two tests in conjunction improves the accuracy of predicting which patients will go on to develop ESRD. According to their analysis, if one uses eGFR and MAU together, the number of patients referred to a nephrologist that ultimately develop ESRD would fall from 38.4 to 11.4. This dramatic reduction implies that these 2 tests when used in conjunction greatly increases the diagnostic and prognostic accuracy of primary care physicians assessing for chronic kidney disease.

For a presentation on this topic, please see these links on UKidney:

Return to UKidney blog home page

Comments

No comments made yet. Be the first to submit a comment

Leave your comment

Guest Friday, 10 February 2012

If you would like to register, please fill in the username and name field

Username (required for registrations)

Automatically register me as a user of this site

Subscribe to updates (Please fill in your email address to subscribe to blog updates.)

UKidney Blog

eGFR and microalbuminuria: a powerful duo

Comments

Leave your comment

Login Form

UKidney Blog

eGFR and microalbuminuria: a powerful duo

ACE and ARB in combination: Still a viable option?

Sodium bicarbonate replacement delays progression of chronic kidney disease

Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes

Hyperphosphatemia management - It is time for a randomized trial

Vitamins are harmful in patients with chronic kidney disease

Comments

Leave your comment

Login Form